1102 results about "Healing wounds" patented technology

The present invention provides a treatment for enhancing the ability of the body to heal wounds. A topical cream is described which improves blood flow by the transdermal delivery of the nitric oxide precursor L-Arginine either alone or with an adjunct, theophylline. The delivery of the active agents is accomplished by use of a vehicle which contains a hostile biophysical environment which is also hostile to hydrogen bond formation.

Polymerized type I and/or III collagen based compositions for medical use as adhesives and sealants and preparation thereof are described. Prior to polymerization, the collagen monomers are prepared recombinantly whereby chemical modifications of the collagen are not needed to form such monomers. The type I and/or III collagen compositions are useful as medical adhesives for bonding soft tissues or in a sealant film for a variety of medical uses. In a further aspect of the present invention, the polymerized type I and/or III collagen composition includes agents which induce wound healing or provide for additional beneficial characteristics desired in a tissue adhesive and sealant.

The Technology described herein applies to medical dressings designed to heal wounds in the area of advanced wound care, inclusive of Negative Pressure Wound Therapy (NPWT), and describes novel wound healing absorbent scaffolds and dressing based on natural and naturally-derived material and fibers, preferentially poly (lactic) acid fibers and alginate materials.

Methods and pharmaceutical compositions for inducing or accelerating a healing process of a damaged skin or skin wound, comprise modulating expression and/or activity of at least two PKC isoforms in skin cells colonizing the damaged skin or skin wound area.

An apparatus and a method for the therapy of a range of dermatological conditions using precisely formulated gaseous milieus featuring the beneficial functions of oxygen and ozone. A range of clinical applications for this system include the therapy of gas gangrene, infected wounds, poorly healing wounds, war wounds, decubitus ulcers, dermatological conditions due to circulatory disorders, lymphatic diseases of the skin, fungal skin infections, burns, nail afflictions, radiodermatitis, parasitic skin infestations, and frostbite.

The invention relates to a prosthesis that can be implanted in the centre of wall wound scarring. The inventive prosthesis, which is intended for use in abdominal surgery, is provided with a geometric shape in the form of sheets that converge in dihedral angles. The sheets or planes are made from a synthetic biotolerated material in porous form with large pores. One of said planes is inserted into the centre of the scarring between the two aponeurotic surfaces to be joined. The other plane(s) of the prosthesis, which is perpendicular to the aforementioned plane, is arranged so as to overlap the aponeurotic edges of the edge of the section. The proliferation obtained around the prosthesis, in the scarring centre and close thereto, provides stress resistance greater than that obtained in standard closures, thereby greatly reducing the risk of hernias caused by a badly healed wound.

The invention discloses a method for preparing a nanofibre membrane, belonging to a technique for preparing a nanofibre compound membrane. The method comprises the following steps: preparing curcuminethanol solution and chitosan acetum, mixing the curcumin ethanol solution and the chitosan acetum by the volume ratio thereof to prepare spinning solution which is injected into an injector of an electrostatic spinning device for electrostatic spinning to form a compound nanofibre membrane and to obtain a curcumin/chitosan nanofibre membrane of antibacterial property, wherein the diameter of thecurcumin/chitosan nanofibre membrane is 200-400 nm. The invention has the advantages that the preparation process is simple, the prepared membrane material heals wound, has broad spectrum bactericidalproperty and has higher bacterial inhibition rate to colibacillus and staphylococcus aureus for 24h.

The invention belongs to the medical material and preparation technology field, and provides a hydrogel antibacterial gauze dressing and a preparation method therefor. Hydrophilic macromolecules and glycerin are dispersed in purified water, mixed and stirred uniformly. After full swelling, inorganic nano-antibacterial agents are added, uniform mixing and stirring are carried out again and a uniform mixture, namely, hydrogel is obtained. Then the obtained hydrogel is painted on a support layer uniformly, and a hydrogel layer is formed. Then protection layers cover the exposed parts of the hydrogel layer and the support layer, and a finished product is obtained. The obtained hydrogel antibacterial gauze dressing has good biological compatibility, wound healing is promoted rapidly, the stability is good, the dressing has no toxic or side effects and the antibacterial effects are obvious.

A bio-adhesive supramacromolecular complex of the general formula:

wherein R₁ is independently selected from the group consisting of an alkane unsubstituted or substituted with alkoxy groups; R₂ is independently selected from the group consisting of C1-6 alkyl; R₃ and R₄ are independently selected from the group consisting of optionally substituted aliphatic or aromatic alkyl; R₅ is independently selected from the group consisting of H or C1-6 alkyl; W is a hydrogen-bond accepting functional group-containing entity; Y is a carboxylic acid ester or amide linkage; R is an independently selected peptide linking group; T₁, T₂, T₃ and T₄ are independently selected polymer residues; and m₁, m₂, m₃, n₁ and n₂ are integers selected from at least 25; and wherein P has a molecular weight of about 1×10³ to 1×10⁷ and Q has a molecular weight of about 1×10³ to 1×10⁷. The complex provides controlled nitric oxide release over a longer period of time than prior art compounds in the locally delivery systems. Novel compositions, methods of preparation, apparatus including layer-by-layer assemblies coating, electrospinning and ultrasonic atomization, skin coverings containing and medical use of the complexes are described.

The invention belongs to the field of biomedical engineering materials and discloses a nitric oxide loaded cationic polymer, a preparation method therefor and an application of the nitric oxide loaded cationic polymer in the field of biomedicine. A cationic polymer which is used for loading nitric oxide and containing a dendritic polyamide element specifically is a polyethyleneimine grafted dendritic polyamide polymer and has a molecular formula shown in the description. The invention further provides the nitric oxide loaded cationic polymer based on the polymer. The nitric oxide loaded cationic polymer disclosed by the invention can be applied to the field of biomedicine as a nitric oxide donor material through loading NO, is used as a biomedical material and particularly is applied to the preparation of antibacterials; and the nitric oxide loaded cationic polymer has the effects of effectively inhibiting the growth and reproduction of bacteria and fungi, has remarkable inhibitory effects on common oral cavity pathogenic bacteria, dermatophyte, wound infection bacteria and the like, has the functions of promoting wound healing, diminishing inflammation and the like and provides a support for the application of the nitric oxide loaded cationic polymer in preparation of the biomedical engineering materials.

The present invention relates to production of polyketides and other natural products and to libraries of compounds and individual novel compounds. Therefore in aspect the present invention provides 17-desmethylrapamycin and analogues thereof, methods for their production, including recombinant strains, and isolation and uses of the compounds of the invention. In a further aspect the present invention provides for the use of 17-desmethylrapamycin and analogues thereof in the induction or maintenance of immunosuppression, the stimulation of neuronal regeneration or the treatment of cancer, B-cell malignancies, fungal infections, transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation vascular disease and fibrotic diseases, and in the regulation of wound healing.

The invention relates to composite materials based on polysilicic acid, said materials containing novel compositions which have improved material properties and can be in the form of dispersions, pastes, powders, granulated materials, layers or compact moulded bodies. The aim of the invention is to produce composite materials based on polysilicic acid with improved mechanical properties. To this end, the composite materials contain polysilicic acid, between 0.01 and 20 mass % of an organic polymer, more than 15 mass % of at least one calcium phosphate phase, and optionally a use-specific additive. The material produced according to the invention can be implanted or injected. The composition of the composite material with the resulting properties enables the composite material to be used for bone substitution and/or bone regeneration in both human medicine and animal medicine. The inventive material can also be used to heal wounds.

The invention discloses a trauma nursing device. The trauma nursing device comprises a shell, an isolation board is arranged on the lower portion of the shell, an absorbent cotton holder is arranged above the isolation board and is filled with absorbent cotton, the left side face of the shell is provided with an opening allowing the absorbent cotton holder to insert into, and a ventilation opening is formed in the right side of the shell. The trauma nursing device has the advantages that the drawing-type absorbent cotton holder is used for holding the absorbent cotton, and medical personnel can only need to draw out the absorbent cotton without uncovering the device during dressing change so as to avoid exposing a wound to air; easily caused laceration of the just healed wound when medical proof fabric and gauze are torn off in every dressing change process is avoided, and inconvenience caused by binding up the wound through gauze traditionally is overcome; a rubber air sac is used for spraying liquid medicine on the absorbent cotton, and accordingly simplicity and convenience in dressing are achieved; the trauma nursing device is provided with a plunger barrel which can be used for providing a negative-pressure environment, removing fester from the festered wound is facilitated; the trauma nursing device is convenient to use and capable of protecting the wound more comprehensively, so that pain of patients is relieved greatly, and working difficulty of medical personnel is lowered.

The invention relates the medical biomaterial technology field. The existing clinical hemostasis dressing is only used for stopping blood, while the new biological dressing is only used for cleaning and healing superficial wounds and lacks a specific direction for treating posttraumatic wound, in particular, sea battle injury. The aim of the invention is to provide a method for preparing a hemostasis dressing with good volume expansibility, permeability, as well as obvious direction to deal with high-permeability seawater. The method for preparing the hemostasis dressing uses sodium alginate mixed by chitosan and various Na<+>/Ca<2+> as the basic material to form a hemostasis sponge with good mechanical strength after being cooled and dried, and prepares asymmetric seawater hemostasis dressing with porous layer and compact layer by using polyvinyl alcohol as the surface coating material. The dressing shows high expansibility and good permeability according to the results of volume expansibility, permeability and sem observation, has rich porous layer and compact water-resistant layer in microstructure, and is applied for stooping blood and healing wounds in high-permeability seawater environment.

The invention discloses a composition containing oligopeptide and oligosaccharide for postoperative group to eat. The composition includes oligopeptide, oligosaccharide and traditional Chinese medicine extractives, wherein the oligopeptide is a mixture of marine collagen peptide, marine bone peptide, lactalbumin and ovalbumin; the oligosaccharide is a mixture of chitosan oligosaccharide and isomaltooligosaccharide; and the traditional Chinese medicine extractives comprise folium mori extractive, rhizoma polygonati extractive and corn stigma extractive. The composition can not only maintain nutrient balance of a postoperative patient but also promote wound healing of the postoperative patient.